Abstract
Diabetes is characterized by unusually elevated blood glucose or levels of sugar. Dietary glucose is produced, and insulin is the hormone that aids glucose entry into cells to provide energy. The occurrence of type 1 diabetes occurs when insulin production does not take place in the body, and type 2 diabetes happens when the body does not appropriately utilize insulin. Persistent abnormal functions and continuous injury to vital organs such as eyes, blood vessels, nerves, kidneys, and heart are the foremost characteristic features of chronic diabetes. Genes related to diabetes risk include TCF7L2, which distress insulin secretion and glucose production. The development of diabetes is mainly associated with various pathogenic processes. In recent years, the prevalence of diabetes and cancer has risen dramatically. Obesity, a sedentary lifestyle, smoking, and aging are frequent hazard issues for diabetes and cancer. According to a large body of epidemiological data, diabetes is a self-governing risk factor for amplified rates of several types of cancer incidence and death. People with diabetes slightly increase the incidence and mortality of several malignancies, namely, pancreatic, liver, colorectal, breast, endometrial, and bladder cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acharjee, S., Ghosh, B., Al-Dhubiab, B. E., & Nair, A. B. (2013). Understanding type 1 diabetes: Etiology and models. Canadian Journal of Diabetes, 37(4), 269–276.
Alam, U., Asghar, O., Azmi, S., & Malik, R. A. (2014). General aspects of diabetes mellitus. In Handbook of clinical neurology (Vol. 126, pp. 211–222). Springer.
Anjos, S., & Polychronakos, C. (2004). Mechanisms of genetic susceptibility to type 1 diabetes: Beyond HLA. Molecular Genetics and Metabolism, 81, 187–195.
Babenko, A. P., Polak, M., Cavé, H., et al. (2006). Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. The New England Journal of Medicine, 355, 456–466.
Billert, M., Skrzypski, M., Sassek, M., Szczepankiewicz, D., Wojciechowicz, T., Mergler, S., Strowski, M. Z., & Nowak, K. W. (2017). TRPV4 regulates insulin mRNA expression and INS-1E cell death via ERK1/2 and NO-dependent mechanisms. Cellular Signalling, 35, 242–249.
Bosetti, C., Turati, F., & La Vecchia, C. (2014). Hepatocellular carcinoma epidemiology. Best Practice & Research. Clinical Gastroenterology, 28, 753–770.
Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., Fairley, L. L., Boniol, M., Zheng, T., Zhang, Y., Pasterk, M., Smans, M., Curado, M. P., Mullie, P., Gandini, S., Bota, M., Bolli, G. B., Rosenstock, J., & Autier, P. (2012). Diabetes and breast cancer risk: A meta-analysis. British Journal of Cancer, 107, 1608–1617.
Brunton, S. (2016). Pathophysiology of Type 2 Diabetes: The evolution of our understanding. The Journal of Family Practice, 65(4 Suppl), supp_az_0416.
Cade, W. T. (2008). Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Physical Therapy, 88(11), 1322–1335. https://doi.org/10.2522/ptj.20080008
Chaudhry, Z. W., Hall, E., Kalyani, R. R., Cosgrove, D. P., & Yeh, H. C. (2013). Diabetes and pancreatic cancer. Current Problems in Cancer, 37, 287–292.
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2011). The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol, 8(4), 228–236.
Cockburn, B. N., Bermano, G., Boodram, L. L., Teelucksingh, S., Tsuchiya, T., Mahabir, D., Allan, A. B., Stein, R., Docherty, K., & Bell, G. I. (2004). Insulin promoter factor-1 mutation and diabetes in Trinidad: Identification of a novel diabetes-associated mutation (E224K) in an indo-Trinidadian family. The Journal of Clinical Endocrinology and Metabolism, 89, 971–978.
Coustan, D. R. (2013). Gestational diabetes mellitus. Clinical Chemistry, 59(9), 1310–1321.
Dong, R., Tan, Y., Fan, A., Liao, Z., Liu, H., & Wei, P. (2020). Molecular dynamics of the recruitment of immunoreceptor signaling module DAP12 homodimer to lipid raft boundary regulated by PIP2. The Journal of Physical Chemistry B, 124, 504–510.
Dorman, J. S., & Bunker, C. H. (2000). HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: A HuGE review. Epidemiologic Reviews, 22, 218–227.
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017). Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight., 2(14), e93751. https://doi.org/10.1172/jci.insight.93751
Esposito, G., Bravi, F., Serraino, D., Parazzini, F., Crispo, A., Augustin, L. S. A., Negri, E., La Vecchia, C., & Turati, F. (2021). Diabetes risk reduction diet and endometrial cancer risk. Nutrients, 13(8), 2630.
Fendrick, A. M., Buxbaum, J. D., Tang, Y., Vlahiotis, A., McMorrow, D., Rajpathak, S., & Chernew, M. E. (2019). Association between switching to a high-deductible health plan and discontinuation of type 2 diabetes treatment. JAMA Network Open, 2(11), e1914372.
Ferguson, R. D., Gallagher, E. J., Cohen, D., Tobin-Hess, A., Alikhani, N., Novosyadlyy, R., Haddad, N., Yakar, S., & LeRoith, D. (2013). Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. Endocrine-Related Cancer, 20, 391–401.
Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107(9), 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
Gill, E., Sandhu, G., Ward, D. G., Perks, C. M., & Bryan, R. T. (2021). The Sirenic links between diabetes, obesity, and bladder cancer. International Journal of Molecular Sciences, 22(20), 11150.
Godsland, I. F. (2009). Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clinical Science (London, England), 118, 315–332.
Grossmann, M., & Wittert, G. (2012). Androgens, diabetes and prostate cancer. Endocrine-Related Cancer, 19(5), F47–F62.
Gunavathy, N., Asirvatham, A., Chitra, A., & Jayalakshmi, M. (2019). Association of CTLA-4 and CD28 gene polymorphisms with type 1 diabetes in south Indian population. Immunological Investigations, 48(6), 659–671.
Gutiérrez-Salmerón, M., Lucena, S. R., Chocarro-Calvo, A., García-Martínez, J. M., Martín Orozco, R. M., & García-Jiménez, C. (2021). Metabolic and hormonal remodeling of colorectal cancer cell signalling by diabetes. Endocrine-Related Cancer, 28(6), R191–R206.
Hirschhorn, J. N. (2003). Genetic epidemiology of type 1 diabetes. Pediatric Diabetes, 4(2), 87–100.
Hu, J., Chen, J. B., Cui, Y., Zhu, Y. W., Ren, W. B., Zhou, X., Liu, L. F., Chen, H. Q., & Zu, X. B. (2018). Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis. Medicine (Baltimore), 97(30), e11596.
Hua, Q., Zhu, Y., Liu, H., & Ye, X. (2016). Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis. International Urology and Nephrology, 48(9), 1437–1443.
Javeed, N., & Matveyenko, A. V. (2018). Circadian etiology of Type 2 Diabetes Mellitus. Physiology (Bethesda, MD), 33(2), 138–150.
Kelkar, S., Oyekunle, T., Eisenberg, A., Howard, L., Aronson, W. J., Kane, C. J., Amling, C. L., Cooperberg, M. R., Klaassen, Z., Terris, M. K., Freedland, S. J., & Csizmadi, I. (2021). Diabetes and prostate cancer outcomes in obese and nonobese men after radical prostatectomy. Journal of the National Cancer Institute Cancer Spectrum, 5(3), pkab023.
Kim, S. H., Ma, X., Weremowicz, S., Ercolino, T., Powers, C., Mlynarski, W., Bashan, K. A., Warram, J. H., Mychaleckyj, J., Rich, S. S., Krolewski, A. S., & Doria, A. (2004). Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. Diabetes, 53, 1375–1384.
Li, W., Huang, E., & Gao, S. (2017). Type 1 diabetes mellitus and cognitive impairments: A systematic review. Journal of Alzheimer’s Disease, 57(1), 29–36.
Liao, Z., Tan, Z. W., Zhu, P., & Tan, N. S. (2019). Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy. Cellular Immunology, 343, 103729.
Lim, A. K. H. (2014). Diabetic nephropathy - complications and treatment. International Journal of Nephrology and Renovascular Disease, 7, 361–381. https://doi.org/10.2147/IJNRD.S40172/
Mantovani, A., & Targher, G. (2017). Type 2 diabetes mellitus and risk of hepatocellular carcinoma: Spotlight on nonalcoholic fatty liver disease. Annals of Translational Medicine, 5, 270.
Morris, A. P., Voight, B. F., Teslovich, T. M., Ferreira, T., Segrè, A. V., Steinthorsdottir, V., Strawbridge, R. J., Khan, H., Grallert, H., Mahajan, A., Prokopenko, I., Kang, H. M., Dina, C., Esko, T., Fraser, R. M., Kanoni, S., Kumar, A., Lagou, V., Langenberg, C., Luan, J., Lindgren, C. M., Müller-Nurasyid, M., Pechlivanis, S., Rayner, N. W., Scott, L. J., Wiltshire, S., Yengo, L., Kinnunen, L., Rossin, E. J., Raychaudhuri, S., Johnson, A. D., Dimas, A. S., Loos, R. J., Vedantam, S., Chen, H., Florez, J. C., Fox, C., Liu, C. T., Rybin, D., Couper, D. J., Kao, W. H., Li, M., Cornelis, M. C., Kraft, P., Sun, Q., van Dam, R. M., Stringham, H. M., Chines, P. S., Fischer, K., Fontanillas, P., Holmen, O. L., Hunt, S. E., Jackson, A. U., Kong, A., Lawrence, R., Meyer, J., Perry, J. R., Platou, C. G., Potter, S., Rehnberg, E., Robertson, N., Sivapalaratnam, S., Stančáková, A., Stirrups, K., Thorleifsson, G., Tikkanen, E., Wood, A. R., Almgren, P., Atalay, M., Benediktsson, R., Bonnycastle, L. L., Burtt, N., Carey, J., Charpentier, G., Crenshaw, A. T., Doney, A. S., Dorkhan, M., Edkins, S., Emilsson, V., Eury, E., Forsen, T., Gertow, K., Gigante, B., Grant, G. B., Groves, C. J., Guiducci, C., Herder, C., Hreidarsson, A. B., Hui, J., James, A., Jonsson, A., Rathmann, W., Klopp, N., Kravic, J., Krjutškov, K., Langford, C., Leander, K., Lindholm, E., Lobbens, S., Männistö, S., Mirza, G., Mühleisen, T. W., Musk, B., Parkin, M., Rallidis, L., Saramies, J., Sennblad, B., Shah, S., Sigurðsson, G., Silveira, A., Steinbach, G., Thorand, B., Trakalo, J., Veglia, F., Wennauer, R., Winckler, W., Zabaneh, D., Campbell, H., van Duijn, C., Uitterlinden, A. G., Hofman, A., Sijbrands, E., Abecasis, G. R., Owen, K. R., Zeggini, E., Trip, M. D., Forouhi, N. G., Syvänen, A. C., Eriksson, J. G., Peltonen, L., Nöthen, M. M., Balkau, B., Palmer, C. N., Lyssenko, V., Tuomi, T., Isomaa, B., Hunter, D. J., Qi, L., Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network–Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium, Shuldiner, A. R., Roden, M., Barroso, I., Wilsgaard, T., Beilby, J., Hovingh, K., Price, J. F., Wilson, J. F., Rauramaa, R., Lakka, T. A., Lind, L., Dedoussis, G., Njølstad, I., Pedersen, N. L., Khaw, K. T., Wareham, N. J., Keinanen-Kiukaanniemi, S. M., Saaristo, T. E., Korpi-Hyövälti, E., Saltevo, J., Laakso, M., Kuusisto, J., Metspalu, A., Collins, F. S., Mohlke, K. L., Bergman, R. N., Tuomilehto, J., Boehm, B. O., Gieger, C., Hveem, K., Cauchi, S., Froguel, P., Baldassarre, D., Tremoli, E., Humphries, S. E., Saleheen, D., Danesh, J., Ingelsson, E., Ripatti, S., Salomaa, V., Erbel, R., Jöckel, K. H., Moebus, S., Peters, A., Illig, T., de Faire, U., Hamsten, A., Morris, A. D., Donnelly, P. J., Frayling, T. M., Hattersley, A. T., Boerwinkle, E., Melander, O., Kathiresan, S., Nilsson, P. M., Deloukas, P., Thorsteinsdottir, U., Groop, L. C., Stefansson, K., Hu, F., Pankow, J. S., Dupuis, J., Meigs, J. B., Altshuler, D., Boehnke, M., McCarthy, M. I., & DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. (2012). Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature Genetics, 44(9), 981–990.
Ozsu, E., Cizmecioglu, F. M., Yesiltepe Mutlu, G., Yuksel, A. B., Calıskan, M., Yesilyurt, A., & Hatun, S. (2018). Maturity onset diabetes of the young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A mutations in a cohort of Turkish children diagnosed as type 1 diabetes mellitus. Hormone Research in Pædiatrics, 90(4), 257–265.
Proks, P., Arnold, A. L., Bruining, J., Girard, C., Flanagan, S. E., Larkin, B., Colclough, K., Hattersley, A. T., Ashcroft, F. M., & Ellard, S. (2006). A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Human Molecular Genetics, 15, 1793–1800.
Pugliese, A., Zeller, M., & Ferndandez, J. A. (1997). The insulin gene is transcribed in human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM 2 susceptibility locus for type 1 diabetes. Nature Genetics, 15, 293–297.
Romer, A. I., Singer, R. A., Sui, L., Egli, D., & Sussel, L. (2019). Murine perinatal Beta cell proliferation and the differentiation of human stem cell derived insulin expressing cells require NEUROD1. Diabetes, 68, 2259.
Sabaratnam, R., Pedersen, A. J., Eskildsen, T. V., Kristensen, J. M., Wojtaszewski, J. F. P., & Hojlund, K. (2019). Exercise induction of key transcriptional regulators of metabolic adaptation in muscle is preserved in type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 104(10), 4909–4920.
Sen, S., & Chakraborty, R. (2015). Treatment and diagnosis of diabetes mellitus and its complication: Advanced approaches. Mini Reviews in Medicinal Chemistry, 15(14), 1132–1133.
Sethi, I., Bhat, G. R., Singh, V., Kumar, R., Bhanwer, A. J., Bamezai, R. N., Sharma, S., & Rai, E. (2016). Role of telomeres and associated maintenance genes in type 2 diabetes mellitus: A review. Diabetes Research and Clinical Practice, 122, 92–100.
Setiawan, V. W., Stram, D. O., Porcel, J., Chari, S. T., Maskarinec, G., Le Marchand, L., Wilkens, L. R., Haiman, C. A., Pandol, S. J., & Monroe, K. R. (2019). Pancreatic cancer following incident diabetes in African Americans and Latinos: The multiethnic Cohort. Journal of the National Cancer Institute, 111, 27–33.
Soltani, G., Poursheikhani, A., Yassi, M., Hayatbakhsh, A., Kerachian, M., & Kerachian, M. A. (2019). Obesity, diabetes and the risk of colorectal adenoma and cancer. BMC Endocrine Disorders, 19(1), 113.
Sugimoto, K., Murakawa, Y., & Sima, A. A. (2000). Diabetic neuropathy: A continuing enigma. Diabetes/Metabolism Research and Reviews, 16(6), 408–433. https://doi.org/10.1002/1520-7560(200011/12)16:6<408::aid-dmrr158>3.0.co;2-r
Trefz, P., Obermeier, J., Lehbrink, R., Schubert, J. K., Miekisch, W., & Fischer, D. C. (2019). Exhaled volatile substances in children suffering from type 1 diabetes mellitus: Results from a cross-sectional study. Scientific Reports, 9(1), 15707.
Urakami, T. (2019). Maturity-onset diabetes of the young (MODY): Current perspectives on diagnosis and treatment. Diabetes, Metabolic Syndrome and Obesity, 12, 1047–1056.
Wang, J., He, C., Gao, P., Wang, S., Lv, R., Zhou, H., Zhou, Q., Zhang, K., Sun, J., Fan, C., Ding, G., & Lan, F. (2019). HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer. Oncogene, 39(6), 1335–1346.
Wartko, P. D., Beck, T. L., Reed, S. D., Mueller, B. A., & Hawes, S. E. (2017). Association of endometrial hyperplasia and cancer with a history of gestational diabetes. Cancer Causes & Control, 28(8), 819–828.
Wu, A. H., Yu, M. C., Tseng, C. C., Stanczyk, F. Z., & Pike, M. C. (2007). Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis, 28, 1561–1566.
Zaccardi, F., Webb, D. R., Yates, T., & Davies, M. J. (2016). Pathophysiology of type 1 and type 2 diabetes mellitus: A 90-year perspective. Postgraduate Medical Journal, 92(1084), 63–69.
Zhang, X., Shi, C., Wei, L., Sun, F., & Ji, L. (2019). The association between the rs2975760 and rs3792267 single nucleotide polymorphisms of Calpain 10 (CAPN10) and gestational diabetes mellitus. Medical Science Monitor, 25, 5137–5142.
Zhou, W., Chen, M., Zhou, H., & Zhang, Z. (2019). Heterozygous lys169Glu mutation of glucokinase gene in a Chinese family having glucokinase-maturity-onset diabetes of the young (GCK-MODY). Journal of Postgraduate Medicine, 65(4), 241–243.
Acknowledgments
Author Dr. K. LANGESWARAN mercifully acknowledges Alagappa University for the infrastructure facility, and RUSA phase 2.0 grant sanctioned vide letter No.F.24–51/2014-U policy (TN Multi-Gen), Dept. of Govt. of India Dt, 09.10.2018.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Nithya, V. et al. (2023). Diabetes and Other Comorbidities: Microvascular and Macrovascular Diseases Diabetes and Cancer. In: Noor, R. (eds) Advances in Diabetes Research and Management. Springer, Singapore. https://doi.org/10.1007/978-981-19-0027-3_2
Download citation
DOI: https://doi.org/10.1007/978-981-19-0027-3_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-0026-6
Online ISBN: 978-981-19-0027-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)